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ABSTRACT
Objectives Monoamniotic twin pregnancies are at
increased risk of perinatal complications, primarily owing
to the risk of cord entanglement. There is no recommen-
dation on whether such pregnancies should be managed
in hospital or can be safely managed in an outpatient
setting, and the timing of planned delivery is also a sub-
ject of debate. The aim of this study was to compare the
perinatal outcomes of inpatient vs outpatient fetal surveil-
lance approaches employed among 22 participating study
centers, and to calculate the fetal and neonatal death rates
according to gestational age, in non-anomalous monoam-
niotic twins from 26weeks’ gestation.
Methods The MONOMONO study was a multinational
cohort study of consecutive women with monochorionic
monoamniotic twin pregnancies, who were referred
to 22 university hospitals in Italy, the USA, the UK
and Spain, from January 2010 to January 2017.
Only non-anomalous uncomplicated monoamniotic twin
pregnancies with two live fetuses at 26+ 0weeks’
gestation were included in the study. In 10 of the
centers, monoamniotic twins were managed routinely
as inpatients, whereas in the other 12 centers they were
managed routinely as outpatients. The primary outcome
was intrauterine fetal death. We also planned to assess
fetal and neonatal death rates according to gestational
age per 1-week interval. Outcomes are presented as
odds ratio (OR) with 95% CIs. The main outcome was
analyzed using both standard logistic regression analysis,
in which each fetus was treated as an independent unit,
and a generalized mixed-model approach, with each
twin pair treated as a cluster unit, considering that the
outcome for a twin is not independent of that of its
cotwin.
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Results 195 consecutive pregnant women with a non-
anomalous uncomplicated monoamniotic twin gestation
(390 fetuses) were included. Of these, 75 (38.5%) were
managed as inpatients and 120 (61.5%) as outpatients.
The overall perinatal loss rate was 10.8% (42/390)
with a peak fetal death rate of 4.3% (15/348) occurring
at 29weeks’ gestation. There was no significant difference
in mean gestational age at delivery (31weeks), birth
weight (∼1.6 kg), or emergency delivery rate between
the inpatient and outpatient surveillance groups. Based
on generalized mixed-model analysis, there was no
statistically significant difference in fetal death rates
between inpatient management commencing from around
26weeks compared with outpatient surveillance protocols
from 30weeks (3.3% vs 10.8%; adjusted OR 0.21 (95%
CI, 0.04–1.17)). Maternal length of stay in the hospital
was 42.1 days in the inpatient group, and 7.4 days in the
outpatient group (mean difference 34.70 days (95% CI,
31.36–38.04 days). From 32+ 0 to 36+ 6weeks, no fetal
or neonatal death in either group was recorded. 46 fetuses
were delivered after 34+ 0weeks, and none of them died
in utero or within the first 28 days postpartum.
Conclusion In uncomplicatedmonoamniotic twins, inpa-
tient surveillance is associated with similar fetal mortality
as outpatient management. After 31+ 6weeks, and up
to 36+6weeks, there were no intrauterine fetal deaths
or neonatal deaths. Copyright  2018 ISUOG. Published
by John Wiley & Sons Ltd.
INTRODUCTION
Monochorionic monoamniotic twinning accounts for
about 1–2% of monozygotic twin pregnancies
worldwide1–6. Monoamniotic twins are at increased risk
of perinatal complications compared with monochorionic
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diamniotic or dichorionic twin pregnancies3–5. Perinatal
mortality is reported to be high in monoamniotic twins,
primarily owing to cord entanglement5. Early- and
mid-pregnancy loss before 26weeks’ gestation seems to
be correlated mainly with the incidence of twin reversed
arterial perfusion (TRAP) sequence, conjoined twins and
major congenital anomalies, the rate of these complica-
tions being as high as 60% in studies evaluating high-risk
referred populations5,7. Regarding pregnancy loss after
26weeks, the largest review of monoamniotic twins,
including 60 studies and 133 non-conjoined monoam-
niotic twin pregnancies, reported a non-anomalous
perinatal mortality rate of about 20%, with a sig-
nificant rise in mortality after 32weeks’ gestation4.
These data are often used to justify planned preterm
delivery from 32weeks in otherwise uncomplicated
monoamniotic twins5,8; however, robust data on which
a decision about the timing of delivery can be based are
missing.
Inpatient management of monoamniotic twin pregnan-
cies from viability until delivery has been reported5. No
recommendation has been made on whether these women
should be managed in hospital or whether they can be
managed safely in an outpatient setting, and The Ameri-
can College of Obstetricians and Gynecologists (ACOG)
concluded that ‘the optimal management of these patients
remains uncertain’8.
The aim of this study was to compare the perina-
tal outcomes of inpatient vs outpatient fetal surveillance
approaches employed in 22 participating study centers,
and to calculate the fetal and neonatal death rate accord-
ing to gestational age, in non-anomalous monoamniotic
twins at ≥ 26weeks’ gestation.
SUBJECTS AND METHODS
Study design and participants
This was a multinational, retrospective, cohort study of
pregnant women with a monochorionic monoamniotic
twin pregnancy who were referred to 22 university
hospitals in Italy, the USA, the UK and Spain (Table 1)
between January 2010 and January 2017. Clinical records
were collected in a dedicated merged database. Only
women with a confirmed diagnosis of monoamnionicity
after delivery were included.
All reported variables were collected for all the subjects
included in the study. Inclusion criteria were gestational
age of at least 26+0weeks with both fetuses alive, and
confirmation of monoamnionicity at delivery and/or by
pathologic examination of the placenta. Only uncom-
plicated monoamniotic twin pregnancies were included.
Exclusion criteria were pseudomonoamnionicity (iatro-
genic creation of a single amniotic space because of an
invasive procedure); conjoined twins; major fetal abnor-
mality; intrauterine growth restriction (IUGR) or selective
IUGR (i.e. one or both fetuses with ultrasound-estimated
fetal weight<10th centile); twin-to-twin transfusion
syndrome; TRAP sequence; acardiac twins; spontaneous
miscarriage before 26weeks; and higher-order multiple
pregnancies. Women who underwent selective reduc-
tion were also excluded. Therefore, all women included
in the study had a non-anomalous uncomplicated
monoamniotic twin pregnancy with both fetuses alive at
26weeks.
In 10 of the centers, all monoamniotic twins were
managed routinely as inpatients, while in the other 12
centers all monoamniotic twins were managed routinely
as outpatients (Table 1). In outpatient care, frequent
follow-up was employed, with regular evaluation of
fetal wellbeing by ultrasound assessment of fetal growth
(fetal biometry of both twins and amniotic fluid volume
assessment using deepest vertical pocket) every 3weeks,
ultrasound Doppler (umbilical artery Doppler and middle
cerebral artery peak systolic velocity for both twins)
every 2weeks9, and non-stress tests (NST) usually once
a week with either standard NST or computerized
cardiotocography.
Women managed as inpatients were admitted from
24+ 0 to 29+0weeks until delivery. Patient management
in this group included NST two or three times a day,
ultrasound assessment of fetal growth every 3weeks and
Doppler ultrasound every 2weeks (Table 1)9. Continuous
fetal heart rate monitoring was not performed in any of
the participating centers.
All women in the inpatient group (study group) were
delivered following one admission. For women included
in the outpatient group (comparison group), who had
one or more admissions, the total length of stay was
calculated.
In both groups, planned Cesarean delivery was sched-
uled usually at 32+0 to 34+ 6weeks, according to local
protocols and at the provider’s discretion (Table 1)8,10.
Any indication for earlier delivery was recorded. Antena-
tal corticosteroids for fetal lung maturation were offered
before planned Cesarean delivery. Assessment of cervi-
cal length by transvaginal ultrasound for the prevention
of preterm birth was not performed routinely in either
group, given the lack of treatment for twin pregnancies
with a short cervix11–16.
Outcomes
Primary and secondary outcomes were compared between
the inpatient and outpatient groups. The primary outcome
was intrauterine fetal death (i.e. stillbirth) after 26weeks’
gestation. Secondary outcomes were gestational age
at delivery, total antenatal maternal length of stay (LOS)
in the hospital, indication for delivery, birth weight, LOS
in the neonatal intensive care unit (NICU) (days from
admission to the NICU until discharge), neonatal death
(i.e. death of a liveborn baby within the first 28 days
postpartum) and perinatal death (i.e. either fetal or
neonatal death).
We also planned to assess fetal and neonatal death
rates according to gestational age at 1-week intervals;
this secondary analysis was performed separately for the
inpatient and outpatient groups.
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Table 1 Protocol followed in participating centers for inpatient or outpatient management of uncomplicated monochorionic monoamniotic
twin pregnancy with two live fetuses at 26weeks’ gestation
Center Protocol
Planned Cesarean
delivery (weeks)
Outpatient management
University of Naples Federico II,
Naples, Italy
US fetal growth every 3weeks; US Doppler every 2weeks; CCTG once
a week starting from 30+0weeks
32+0 to 34+6
Careggi Hospital University of
Florence, Florence, Italy
US fetal growth every 2weeks; US Doppler every 1week; only one
CCTG on day before planned Cesarean delivery
32+0 to 33+6
University of Chieti, Chieti, Italy US fetal growth every 3weeks; US Doppler every 2weeks; CCTG once
a week starting from 30+0weeks
32+0 to 33+6
University of Padua, Padua, Italy US fetal growth every 3weeks; US Doppler every 2weeks; CCTG once
a week starting from 30+0weeks
32+0 to 35+6
University of Udine, Udine, Italy US fetal growth every 3weeks; US Doppler every 2weeks; CCTG once
a week starting from 30+0weeks
32+0 to 33+6
Magna Graecia University of
Catanzaro, Catanzaro, Italy
US fetal growth every 4weeks; US Doppler every 2weeks; CCTG once
a week starting from 30+0weeks
33+0 to 36+6
University Tor Vergata, Rome, Italy US fetal growth every 3weeks; US Doppler every 2weeks; CCTG once
a week starting from 30+0weeks
32+0 to 32+6
University of Sapienza, Rome, Italy US fetal growth every 3weeks; US Doppler every 2weeks; CCTG once
a week starting from 30+0weeks
33+0 to 33+6
Buzzi Children’s Hospital, Milan,
Italy
US fetal growth and US Doppler every 2weeks between 16 and
24weeks, then weekly
32+0 to 32+6
Hospital General Universitario de
Ciudad Real, Ciudad Real, Spain
US fetal growth every 3weeks; US Doppler every 2weeks; only one
CCTG on day before planned Cesarean delivery
32+0 to 32+6
Hospital General Universitario
Gregorio Maranon, Madrid, Spain
US fetal growth every 3weeks; US Doppler every 2weeks; CCTG once
a week starting from 30+0weeks
33+0 to 34+6
University College London Hospitals
(UCLH), London, UK
US fetal growth every 2weeks; US Doppler every 2weeks; CCTG once
a week starting from 30+0weeks
32+0 to 35+0
Inpatient management
Treviso Hospital, Treviso, Italy Admission between 27+0 and 27+6weeks; US fetal growth every
2weeks; US Doppler every week; CCTG once or twice a day
32+0 to 32+6
St Orsola Malpighi Hospital,
University of Bologna, Bologna, Italy
Admission between 27+0 and 27+6weeks; US fetal growth every
2weeks; US Doppler every week; CCTG once or twice a day
32+0 to 33+6
University of Parma, Parma, Italy Admission between 24+0 and 24+6weeks; US fetal growth every
2weeks; US Doppler twice a week; NST twice a day
32+0 to 32+6
University of Brescia, Brescia, Italy Admission between 28+0 and 28+6weeks; US fetal growth every
2weeks; US Doppler every week; CCTG twice a day
32+0 to 32+6
University of Turin, Turin, Italy Admission between 28+0 and 29+0weeks; US fetal growth every
2weeks; US Doppler twice a week; CCTG two or three times a day
32+0 to 33+0
Thomas Jefferson University,
Philadelphia, PA, USA
Admission between 26+0 and 27+6weeks; US fetal growth every
3weeks; US Doppler every 2weeks; NST three times a day
32+0 to 33+0
The Johns Hopkins Hospital,
Baltimore, MD, USA
Admission between 26+0 and 27+6weeks; US fetal growth every
3weeks; US Doppler every 2weeks; NST three times a day
32+0 to 33+0
University of Massachusetts-Baystate,
Springfield, MA, USA
Admission between 26+0 and 27+6weeks; US fetal growth every
3weeks; US Doppler every 2weeks; NST three times a day
32+0 to 32+6
Baylor College of Medicine, Houston,
TX, USA
Admission between 26+0 and 27+6weeks; US fetal growth every
3weeks; US Doppler every 2weeks; NST three times a day
32+0 to 34+6
Hospital Universitario Central de
Asturias (HUCA), Oviedo, Spain
Admission between 27+0 and 27+6weeks; US fetal growth every
2weeks; US Doppler every 2weeks; NST twice a day
32+0 to 34+6
Ultrasound (US) assessment of fetal growth included fetal biometry of both twins and amniotic fluid volume assessment using deepest
vertical pocket method. US Doppler assessment included umbilical artery Doppler and middle cerebral artery peak systolic velocity
assessment, in both twins. CCTG, computerized cardiotocography; NST, non-stress test.
Statistical analysis
Statistical analysis was performed using the Statistical
Package for Social Sciences (SPSS) v. 19.0 (IBM Inc.,
Armonk, NY, USA). Data are shown as mean± SD,
median (range) or n (%). Univariate comparisons of
dichotomous data were performed using the chi-square
test with continuity correction. Comparisons between
groups were performed using the t-test to test means
with SD by assuming equal within-group variance, and
the Mann–Whitney U-test to test group medians with
range. Primary and secondary outcomes are presented
as odds ratios (ORs) with 95% CIs17. In addition to
standard logistic regression analysis, in which each fetus
was treated as an independent unit, we used a gener-
alized mixed-model approach in which each twin pair
was a cluster unit. This model was used because the
outcome of a twin is not independent of that of its
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cotwin. Two-sided P-values were calculated, and P< 0.05
was considered to indicate statistical significance18.
The study was reported following the STROBE
guidelines19.
RESULTS
In total, 195 consecutive women with a non-anomalous
uncomplicated monoamniotic twin pregnancy (390
fetuses) and both fetuses alive at 26weeks, were included
in the study (Figure 1). Of these, 75 (38.5%) women were
managed as inpatients and 120 (61.5%) as outpatients.
Inpatient and outpatient management policies were highly
variable between the included centers. Inpatient monitor-
ing usually started at about 26weeks’ gestation, whereas
in the outpatient group monitoring was usually instituted
after 30weeks (Table 1). Demographic characteristics
were similar between the two groups (Table 2). Mean
maternal age was about 30 years in both groups. One
woman in the inpatient group and one in the outpatient
group had a history of stillbirth in a prior pregnancy.
Primary analysis
Based on standard logistic regression analysis, non-
anomalous uncomplicated monoamniotic twin pregnan-
cies managed as inpatients from 26weeks to delivery had
a significantly lower rate of intrauterine fetal death (3.3%
vs 10.8%; OR, 0.28 (95% CI, 0.11–0.76)) and perinatal
death (4.0% vs 15.0%; OR, 0.24 (95% CI, 0.10–0.58)),
and shorter length of NICU stay by approximately 16 days
(mean difference (MD) –15.90 days (95% CI, –23.6 to
–8.25 days)), comparedwith pregnancies managed as out-
patient. Mean maternal LOS in the hospital was 42.1 days
in the inpatient group and 7.4 days in the outpatient
group (MD, 34.70 days (95% CI, 31.36–38.04 days))
(Table 3).
However, based on generalized mixed-model ana-
lysis considering each twin pair as a cluster unit,
non-anomalous uncomplicated monoamniotic twin preg-
nancies managed as inpatient had a similar rate of
intrauterine fetal death as did those managed as out-
patient (raw rates: 3.3% vs 10.8%; adjusted OR, 0.21
(95% CI, 0.04–1.17); Table 4).
Indications for delivery are shown in Table 5. 70.7%
of the women in the inpatient group and 68.3% of the
women in the outpatient group delivered via scheduled
Cesarean section on the planned date.
Secondary analysis
The overall fetal, neonatal and perinatal death rates in our
cohort were 7.9% (31/390), 2.8% (11/390) and 10.8%
(42/390), respectively. Four (5.3%) women in the
inpatient group and 15 (12.5%) in the outpatient group
experienced intrauterine fetal death. Details of fetal,
neonatal and perinatal deaths according to gestational age
at delivery are shown in Tables 6, S1 and S2, respectively.
The intrauterine fetal death rate per 1-week gestational-
age interval ranged from 0% to 4.3%. The highest
Twin pregnancies, with confirmed
monoamnionicity, recruited
from 22 university hospitals
(n = 392) 
Non-anomalous uncomplicated
monoamniotic twin pregnancies
included in analysis
(n = 195; 390 fetuses) 
Inpatient management
(n = 75 (38.5%); 
150 fetuses)
Outpatient management
(n = 120 (61.5%); 
240 fetuses)
Excluded (n = 197):
 Fetal death of one or both twins
 before 26 weeks (n = 44)
 Termination of pregnancy (n = 17)
 Major fetal abnormality (n = 25)
 Intrauterine growth restriction
 (n = 67)
 Pseudoamnionicity (n = 1)
 TTTS or TRAP (n = 37)
 Selective reduction from triplets
 (n = 6)
Figure 1 Flowchart showing inclusion in study of uncomplicated
monochorionic monoamniotic twin pregnancies with two live
fetuses at 26weeks’ gestation. TRAP, twin reversed arterial
perfusion; TTTS, twin–twin transfusion syndrome.
Table 2 Baseline characteristics of 195 women with uncomplicated
monochorionic monoamniotic twin pregnancy with two live fetuses
at 26weeks’ gestation, according to whether they were managed as
inpatients or outpatients
Characteristic
Inpatient
management
(n= 75)
Outpatient
management
(n=120) P
Age (years) 28.8± 5.5 30.0±4.3 0.12
Assisted reproductive technology 5 (6.7) 10 (8.3) 0.88
Body mass index (kg/m2) 25.5± 5.3 26.2±5.5 0.40
Smoker during pregnancy 9 (12.0) 11 (9.2) 0.71
Ethnicity 0.12
White 59 (78.7) 107 (89.2)
African-American 6 (8.0) 6 (5.0)
Other* 10 (13.3) 7 (5.8)
Gravidity 2 (1–8) 2 (1–7) 0.54
Parity 1 (0–4) 1.5 (0–4) 0.77
Prior stillbirth 1 (1.3) 1 (0.8) 0.99
Data are presented as mean± SD, n (%) or median (range).
*Includes Asian and Hispanic.
weekly intrauterine fetal death rate was observed
between 29+ 0 and 29+ 6weeks, in both the inpa-
tient group (rate, 2.0%) and the outpatient group
(rate, 6.0%).
From 32+ 0 to 36+6weeks, no fetal or neonatal death
occurred in either group (Tables 6 and S1), with 0/46
perinatal deaths between 34+ 0 and 34+6weeks, 0/20
between 35+ 0 and 35+ 6weeks and 0/10 between 36+0
and 36+ 6weeks (Table S2).
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Table 3 Maternal, fetal and neonatal outcomes of 195 uncomplicated monochorionic monoamniotic twin pregnancies with two live fetuses
at 26weeks’ gestation, according to whether they were managed as inpatients or outpatients
Variable
Inpatient
management
Outpatient
management
Mean difference
(95% CI)
OR
(95% CI) P*
Maternal outcomes
Number of women 75 120
Gestational age at delivery (weeks) 31.6±1.7 31.5± 2.4 –0.10 (–0.48 to 0.68) — 0.64
Maternal LOS in hospital (days) 42.1±14.5 7.4± 3.4 34.70 (31.36 to 38.04) — < 0.01
Fetal and neonatal outcomes
Number of fetuses 150 240
Intrauterine fetal death 5 (3.3) 26 (10.8) — 0.28 (0.11 to 0.76) 0.01
Neonatal death 1 (0.7) 10 (4.2) — 0.15 (0.02 to 1.22) 0.08
Perinatal death 6 (4.0) 36 (15.0) — 0.24 (0.10 to 0.58) < 0.01
Neonatal outcomes based on liveborn babies only
Number of liveborn neonates 145 214
Birth weight (g)† 1646±343 1616± 411 30.00 (–48.42 to 108.42) — 0.45
LOS in NICU (days)† 24.3±18.4 40.2± 52.5 –15.90 (–23.55 to –8.25) — < 0.01
Neonatal mortality† 1 (0.7) 10 (4.2) — 0.15 (0.02 to 1.22) 0.08
Data are presented as n, mean ± SD or n (%). *Standard logistic regression analysis, in which each fetus was treated as an independent unit.
†Outcomes based on liveborn babies only. LOS, length of stay; NICU, neonatal intensive care unit; OR, odds ratio.
Table 4 Potential predictors of intrauterine fetal death in
uncomplicated monochorionic monoamniotic twin pregnancies
with two live fetuses at 26weeks’ gestation
Predictor OR (95% CI) P*
Inpatient vs outpatient management 0.21 (0.04–1.17) 0.07
Gestational age, 1-week increase 0.55 (0.36–0.89) 0.006
Birth-weight discordance, 1% increase 1.03 (0.93–1.14) 0.6
*Generalized mixed-model analysis, treating twin pair as cluster
unit. OR, odds ratio.
DISCUSSION
Main findings
In addition to the general risks of monochorionicity
and twin pregnancy, monoamniotic twins are at greatly
increased risk of neonatal death owing to umbilical cord
entanglement. In the past, these risks have been associated
with a loss rate as high as 70%5,13–20. In this cohort of
390 uncomplicated monoamniotic fetuses, the overall rate
of perinatal death was 10.8%.
Based on standard logistic regression analysis, in
which each fetus was treated as an independent unit,
the rate of intrauterine fetal death was significantly
lower in the women managed as inpatients than in
those managed as outpatients. We also observed an
improvement in neonatal outcomes, with inpatient
management associated with a shorter LOS in the
NICU. However, using generalized mixed-model analysis,
with each twin pair treated as a cluster unit, the
rate of intrauterine fetal death was similar between
inpatient- and outpatient-management groups. Therefore,
our study shows that when treating each fetal death as
an independent event, there appears to be a statistically
significant difference between inpatient and outpatient
groups. However, because second twins have an increased
risk of fetal death after the death of a first twin, this finding
did not reach statistical difference when twin pairs were
analyzed as a cluster unit.
Inpatient monitoring usually started at about 26weeks’
gestation, whereas monitoring was delayed until 30weeks
in the outpatient group. Our study showed that the
difference in fetal mortality between the inpatient and the
outpatient groups mainly occurred in the 26–30-week
window, and that once monitoring has been instituted
(be it in the inpatient or in the outpatient group) survival
of monoamniotic twins is excellent, and outcomes of
inpatient and outpatient groups are similar. Therefore,
this study shows clearly that close monitoring is needed
to achieve good outcomes in monoamniotic pregnancies,
regardless of the surveillance setting.
An important finding of this study is the markedly
improved perinatal survival compared with that reported
in older literature. This could be explained by improve-
ments in the diagnosis and treatment of monoamniotic
twin pregnancies but also by the fact that most losses
in these pregnancies are attributable to fetal abnormal-
ities and spontaneous early miscarriage5, which were
excluded from our study. Therefore, these data may truly
represent the natural history of non-anomalous uncom-
plicated monoamniotic twins once viability has been
reached.
Our secondary analysis also showed that fetal death
in non-anomalous uncomplicated monoamniotic twins
occurred up to 31+ 6weeks. Indeed, the major important
and novel finding of the MONOMONO study was
the lack of ‘late-gestational-age’ deaths, suggesting that
putting back the planned timing of delivery from 32
to 34+ 6weeks may be a safe approach for pregnant
women with an uncomplicated monoamniotic twin
pregnancy. However, while no deaths occurred after
34weeks, only 23 pregnancies continued beyond this
gestation, hence the study was underpowered to draw
conclusions on the optimal timing of delivery to avoid
stillbirth.
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Table 5 Indication for delivery by Cesarean section in 195 uncomplicated monochorionic monoamniotic twin pregnancies with two live
fetuses at 26weeks’ gestation, according to whether they were managed as inpatients or outpatients
Indication for delivery
Inpatient
management
(n=75)
Outpatient
management
(n= 120) OR (95% CI) P
Maternal 1 (1.3)* 6 (5.0)† 0.26 (0.03–2.18) 0.21
Fetal 11 (14.7) 8 (6.7) 2.41 (0.92–6.29) 0.07
Planned delivery 53 (70.7) 82 (68.3) 1.12 (0.60–2.09) 0.73
Spontaneous onset of labor before planned delivery 10 (13.3) 24 (20.0) 0.62 (0.28–1.37) 0.24
Data are presented as n (%). *One case of pre-eclampsia. †Four cases of pre-eclampsia; two cases of placental abruption. OR, odds ratio.
Table 6 Incidence of intrauterine fetal death in 195 uncomplicated monochorionic monoamniotic twin pregnancies (n=390 fetuses) with
two live fetuses at 26weeks’ gestation, according to whether they were managed as inpatients or outpatients, by 1-week gestational-age
intervals
Inpatient management (n= 150 fetuses) Outpatient management (n=240 fetuses)
Gestational age
(weeks)
Total cohort
(n= 390 fetuses)
n/N (%)* n/N (%)* Details n/N (%)* Details
27+0 to 27+ 6 5/390 (1.3) 1/150 (0.7) 1 single death 4/240 (1.7) 2 double deaths
28+0 to 28+ 6 6/368 (1.6) 0/148 (0) — 6/220 (2.7) 2 double deaths; 2 single deaths
29+0 to 29+ 6 15/348 (4.3) 3/148 (2.0) 1 single death; 1 double death 12/200 (6.0) 5 double deaths; 2 single deaths
30+0 to 30+ 6 3/299 (1.0) 1/135 (0.7) 1 single death 2/164 (1.2) 1 double death
31+0 to 31+ 6 2/278 (0.7) 0/120 (0) — 2/158 (1.3) 1 double death
32+0 to 32+ 6 0/240 (0) 0/100 (0) — 0/140 (0) —
33+0 to 33+ 6 0/134 (0) 0/34 (0) — 0/100 (0) —
34+0 to 34+ 6 0/46 (0) 0/10 (0) — 0/36 (0) —
35+0 to 35+ 6 0/20 (0) 0/0 (0) — 0/20 (0) —
36+0 to 36+ 6 0/10 (0) 0/0 (0) — 0/10 (0) —
Overall 31/390 (7.9) 5/150 (3.3) 3 single deaths; 1 double death 26/240 (10.8) 4 single deaths; 11 double deaths
*Denominator is total number of live fetuses at that gestational age, i.e. excluding fetal deaths and delivered babies. OR, odds ratio.
The most important limitation of our study was the
retrospective non-randomized approach. Owing to the
retrospective nature of the study, it was not possible
to separate the importance of hospitalization vs the
increased frequency of testing per se. Because this was
not a randomized comparison, the findings were subject
to bias. Moreover, since continuous fetal heart rate
monitoring was not performed in any of the institutions
following inpatient management, it was not possible
to assess whether such a monitoring approach could
further decrease the rate of fetal death. Inpatient and
outpatient management were highly dissimilar between
the included centers (Table 1), and therefore variations
in management among the different institutions could
have influenced our findings. Data on patient satisfaction,
neonatal outcomes and economic implications were not
available.
Comparison with the literature and implications
Several small studies evaluating perinatal outcomes
in monoamniotic twins have been published (Table
S3)7,20–26. In a retrospective study, Heyborne et al.20
assessed the effectiveness of inpatient monitoring of
monoamniotic twins, and observed improved neonatal
survival among women who were admitted electively
for inpatient monitoring. On the other hand, Van
Mieghem et al.22 concluded that if close fetal surveillance
is instituted after 26–28weeks and delivery takes place
at approximately 32–34weeks, the risk of perinatal
complications is low, regardless of the surveillance
setting.
Fetal demise is a major concern as a monoamniotic
twin pregnancy approaches term, and early delivery
would prevent this occurrence. It is indeed common for
monoamniotic twins to be delivered preterm with planned
Cesarean section at about 32weeks’ gestation5,8. In 2016,
the Royal College of Obstetricians and Gynaecologists,
ACOG and the Society for Maternal Fetal Medicine
recommended that monoamniotic twin pregnancies
should be delivered by Cesarean section between 32
and 33weeks because of the high risk of intrauterine
fetal death8,27. These recommendations are based on
studies demonstrating that the perinatal mortality rate
roughly doubles beyond 34weeks (7%) compared with
that at 33weeks (4%)4. However, the justification for
preterm delivery should be balanced against the likelihood
of respiratory distress syndrome (5%) at 32weeks1,7,
despite the use of antenatal steroids28–30 in otherwise
uncomplicated pregnancies1,3,4,8. This balance may not
be achieved if fetal loss in uncomplicated monoamniotic
twins is low1,4. Our study showed no fetal or neonatal
death between 31+6weeks and 36+ 6weeks.
Conclusions
In uncomplicated monoamniotic twins, inpatient surveil-
lance is associated with similar fetal mortality to that
Copyright  2018 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2018.
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of outpatient management. As the raw rates of fetal mor-
tality were 3.3% in the inpatient group and 10.8% in the
outpatient group, further research is necessary.
Our data also suggest that, in non-anomalous uncom-
plicated monoamniotic twins, the fetal and neonatal death
rates do not increase after 32+ 0weeks, therefore planned
Cesarean delivery at 33+ 0 to 34+ 6weeks is a reasonable
strategy to discuss with the patient. Data beyond 34weeks
are too limited to make a recommendation. Owing to
the retrospective nature of this study, caution should be
exercised before changes in practice are employed. A ran-
domized controlled trial would provide the best evidence
on the preferred method of monitoring for monoamniotic
twins, however, this would be logistically difficult given
the rarity of such pregnancies.
The MONOMONO Working Group
Gabriele Saccone*, Department of Neuroscience, Repro-
ductive Sciences and Dentistry, School of Medicine,
University of Naples Federico II, Naples, Italy
Vincenzo Berghella, Division of Maternal-Fetal Medicine,
Department of Obstetrics and Gynecology, Sidney
Kimmel Medical College of Thomas Jefferson Univer-
sity, Philadelphia, PA, USA
Mariavittoria Locci, Department of Neuroscience, Repro-
ductive Sciences and Dentistry, School of Medicine,
University of Naples Federico II, Naples, Italy
Tullio Ghi, Department of Obstetrics and Gynecology,
University of Parma, Parma, Italy
Tiziana Frusca, Department of Obstetrics and Gynecol-
ogy, University of Parma, Parma, Italy
Mariano Lanna, Fetal therapy Unit ‘U Nicolini’, Buzzi
Children’s Hospital University of Milan, Milan, Italy
Stefano Faiola, Fetal therapy Unit ‘U Nicolini’, Buzzi
Children’s Hospital University of Milan, Milan, Italy
Anna Fichera, Department of Obstetrics and Gynecology,
University of Brescia, Brescia, Italy
Federico Prefumo, Department of Obstetrics and Gyne-
cology, University of Brescia, Brescia, Italy
Giuseppe Rizzo, University of Roma Tor Vergata,
Division of Maternal Fetal Medicine, Ospedale Cristo
Re Roma, Rome, Italy
Costanza Bosi, University of Roma Tor Vergata, Division
of Maternal Fetal Medicine, Ospedale Cristo Re Roma,
Rome, Italy
Bruno Arduino, Department of Neuroscience, Reproduc-
tive Sciences and Dentistry, School of Medicine,
University of Naples Federico II, Naples, Italy
Pietro D’Alessandro, Department of Neuroscience,
Reproductive Sciences and Dentistry, School of
Medicine, University of Naples Federico II, Naples,
Italy
Maria Borgo, Department of Neuroscience, Reproductive
Sciences and Dentistry, School of Medicine, University
of Naples Federico II, Naples, Italy
Silvana Arduino, Department of Obstetrics and Gynecol-
ogy, 2nd University of Turin, AO Town of Health and
Science, Turin, Italy
Elisabetta Cantanna, Department of Obstetrics and
Gynecology, 2nd University of Turin, AO Town of
Health and Science, Turin, Italy
Giuliana Simonazzi, Department of Medical Surgical
Sciences, Division of Obstetrics and Prenatal Medicine,
St Orsola Malpighi Hospital, University of Bologna,
Bologna, Italy
Nicola Rizzo, Department of Medical Surgical Sciences,
Division of Obstetrics and Prenatal Medicine, St Orsola
Malpighi Hospital, University of Bologna, Bologna,
Italy
Giorgetta Francesca, Department of Medical Surgical
Sciences, Division of Obstetrics and Prenatal Medicine,
St Orsola Malpighi Hospital, University of Bologna,
Bologna, Italy
Viola Seravalli, Department of Health Science, Division of
Pediatrics, Obstetrics and Gynecology Careggi Hospital
University of Florence, Florence, Italy; Johns Hopkins
Center for Fetal Therapy, Department of Gynecology &
Obstetrics, Johns Hopkins University School of
Medicine, Baltimore, MD, USA
Jena L. Miller, Johns Hopkins Center for Fetal Therapy,
Department of Gynecology & Obstetrics, Johns
Hopkins University School of Medicine, Baltimore,
MD, USA
Elena Rita Magro-Malosso, Department of Health
Science, Division of Pediatrics, Obstetrics and Gyne-
cology Careggi Hospital University of Florence, Flo-
rence, Italy
Mariarosaria Di Tommaso, Department of Health
Science, Division of Pediatrics, Obstetrics and
Gynecology Careggi Hospital University of Florence,
Florence, Italy
Andrea Dall’Asta, Department of Obstetrics and Gyne-
cology, University of Parma, Parma, Italy
Letizia Galli, Department of Obstetrics and Gynecology,
University of Parma, Parma, Italy
Nicola Volpe, Department of Obstetrics and Gynecology,
University of Parma, Parma, Italy
Silvia Visentin, Department of Woman’s and Child’s
Health, University of Padua, Padua, Italy
Erich Cosmi, Department ofWoman’s andChild’s Health,
University of Padua, Padua, Italy
Laura Sarno, Department of Neuroscience, Reproductive
Sciences and Dentistry, School of Medicine, University
of Naples Federico II, Naples, Italy
Claudia Caissutti, Department of Experimental Clinical
and Medical Science, DISM, Clinic of Obstetrics and
Gynecology, University of Udine, Udine, Italy
Lorenza Driul, Department of Experimental Clinical
and Medical Science, DISM, Clinic of Obstetrics and
Gynecology, University of Udine, Udine, Italy
Hannah Anastasio, Division of Maternal-Fetal Medicine,
Department of Obstetrics and Gynecology, Sidney
Kimmel Medical College of Thomas Jefferson Univer-
sity, Philadelphia, PA, USA
Daniele Di Mascio, Department of Gynecological,
Obstetrical and Urological Sciences, Sapienza Univer-
sity of Rome, Rome, Italy
Copyright  2018 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2018.
8 MONOMONO working group
Pierluigi Benedetti Panici, Department of Gynecological,
Obstetrical and Urological Sciences, Sapienza University
of Rome, Rome, Italy
Flaminia Vena, Department of Gynecological, Obstetrical
and Urological Sciences, Sapienza University of Rome,
Rome, Italy
Roberto Brunelli, Department of Gynecological, Obstetri-
cal and Urological Sciences, Sapienza University of
Rome, Rome, Italy
Andrea Ciardulli, Department of Obstetrics and Gynecol-
ogy, Catholic University of Sacred Heart, Rome, Italy
Francesco D’Antonio, Department of Obstetrics and
Gynecology, University Hospital of Northern Norway,
Tromsø, Norway; Department of Obstetrics and
Gynecology, University of Chieti, Chieti, Italy
Corina Schoen, Division of Maternal-Fetal Medicine,
Department of Obstetrics and Gynecology, University
of Massachusetts-Baystate, Springfield, MA, USA
Anju Suhag, Division of Maternal-Fetal Medicine,
Department of Obstetrics and Gynecology, Baylor
College of Medicine, Houston, TX, USA
Zita Maria Gambacorti-Passerini, Department of Obstet-
rics and Gynecology, Hospital General Universitario de
Ciudad Real, Ciudad Real, Spain
Maria Angeles Anaya Baz, Department of Obstetrics and
Gynecology, Hospital General Universitario de Ciudad
Real, Ciudad Real, Spain
Giulia Magoga, Department of Obstetrics and Gynecol-
ogy, Treviso, Italy
Enrico Busato, Department of Obstetrics andGynecology,
Santa Maria di Ca’ Foncello Hospital, Treviso, Italy
Elisa Filippi, Department of Obstetrics and Gynecology,
Santa Maria di Ca’ Foncello Hospital, Treviso, Italy
Marı´a Jose´ Rodriguez Sua´rez, Department of Obstetrics
and Gynecology, Hospital Universitario Central de
Asturias (HUCA), Oviedo, Spain
Francisco Gamez Alderete, Department of Obstetrics
and Gynecology, Hospital General Universitario Gre-
gorio Maranon, Madrid, Spain
Paula Alonso Ortuno, Department of Obstetrics and
Gynecology, Hospital General Universitario Gregorio
Maranon, Madrid, Spain
Amerigo Vitagliano, Department of Woman’s and Child’s
Health, University of Padua, Padua, Italy
Antonio Mollo, Department of Neuroscience, Reproduc-
tive Sciences and Dentistry, School of Medicine,
University of Naples Federico II, Naples, Italy
Antonio Raffone, Department of Neuroscience, Repro-
ductive Sciences and Dentistry, School of Medicine,
University of Naples Federico II, Naples, Italy
Marianne Vendola, University College of London
(UCLH), London, UK
Preethi Navaneethan, University College of London
(UCLH), London, UK
Ruwan Wimalasundera, University College of London
(UCLH), London, UK
Raffaele Napolitano, University College of London
(UCLH), London, UK
Carmen Imma Aquino, School of Medicine, University of
Salerno, Salerno, Italy
Serena D’Agostino, Department of Obstetrics and
Gynaecology, School of Medicine, Magna Graecia
University of Catanzaro, Catanzaro, Italy
Cinzia Gallo, Department of Obstetrics and Gynaecology,
School of Medicine, Magna Graecia University of
Catanzaro, Catanzaro, Italy
Giuseppe Maria Maruotti, Department of Neuroscience,
Reproductive Sciences and Dentistry, School of
Medicine, University of Naples Federico II, Naples,
Italy
Maria Elena Flacco, University of Ferrara, Ferrara, Italy
Ahmet A. Baschat, Johns Hopkins Center for Fetal
Therapy, Department of Gynecology & Obstetrics,
Johns Hopkins University School of Medicine, Balti-
more, MD, USA
Roberta Venturella, Department of Obstetrics and
Gynaecology, School of Medicine, Magna Graecia
University of Catanzaro, Catanzaro, Italy
Maurizio Guida, School of Medicine, University of
Salerno, Salerno, Italy
Pasquale Martinelli, Department of Obstetrics and
Gynaecology, School of Medicine, Magna Graecia
University of Catanzaro, Catanzaro, Italy
Fulvio Zullo, Department of Neuroscience, Reproductive
Sciences and Dentistry, School of Medicine, University
of Naples Federico II, Naples, Italy
*First author of this work.
ACKNOWLEDGMENT
We thank Lamberto Manzoli, Full Professor at Local
Health Unit, University of Pescara, Pescara, Italy,
for providing assistance with the statistical analysis.
REFERENCES
1. Cordero L, Franco A, Joy SD. Monochorionic monoamniotic twins: neonatal
outcome. J Perinatol, 2006; 26: 170–175.
2. Hall JG. Twinning. Lancet 2003; 362: 735–743.
3. Ishii K. Prenatal diagnosis and management of monoamniotic twins. Curr Opin
Obstet Gynecol 2015; 27: 159–164.
4. Roque´ H, Gillen-Goldstein J, Funai E, Young BK, Lockwood CJ. Perinatal outcomes
in monoamniotic gestations. J Matern Fetal Neonatal Med 2003; 13: 414–421.
5. Dias T, Thilaganathan B, Bhide A. Monoamniotic twin pregnancy.Obstet Gynaecol
2012; 14: 71–78.
6. Maruotti GM, Saccone G, Morlando M, Martinelli P. First-trimester ultrasound
determination of chorionicity in twin gestations using the lambda sign: a systematic
review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2016; 202: 66–70.
7. Ezra Y, Shveik D, Ophir E, Nadjari M, Eisenberg VH, Samueloff A,
Rojansky N. Intensive management and early delivery reduce antenatal mortality in
mono-amniotic twin pregnancy. Acta Obstet Gynecol Scand 2005; 84: 432–435.
8. The American College of Obstetricians and Gynecologists and Society for Maternal
Fetal Medicine. Practice Bulletin Number 169: Multifetal Gestations: Twin, Triplet,
and Higher-Order Multifetal Pregnancies. Obstet Gynecol 2016; 128: e131–146.
9. Khalil A, Rodgers M, Baschat A, Bhide A, Gratacos E, Hecher K, Kilby MD, Lewi L,
Nicolaides KH, Oepkes D, Raine-Fenning N, Reed K, Salomon LJ, Sotiriadis A,
Thilaganathan B, Ville Y. ISUOG Practice Guidelines: role of ultrasound in twin
pregnancy. Ultrasound Obstet Gynecol 2016; 47: 247–263.
10. Saccone G, Berghella V. Planned delivery at 37 weeks in twins: a systematic review
and meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med
2016; 29: 685–689.
11. Berghella V, Saccone G. Twins with short cervix: hope ahead. BJOG 2017; 124:
1174.
12. Saccone G, Rust O, Althuisius S, Roman A, Berghella V. Cerclage for short cervix
in twin pregnancies: systematic review and meta-analysis of randomized trials using
individual patient-level data. Acta Obstet Gynecol Scand 2015; 94: 352–358.
Copyright  2018 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2018.
Management and timing of delivery of monoamniotic twins 9
13. Roman A, Rochelson B, Martinelli P, Saccone G, Harris K, Zork N, Spiel M,
O’Brien K, Calluzzo I, Palomares K, Rosen T, Berghella V, Fleischer A. Cerclage in
twin pregnancy with dilated cervix between 16 to 24 weeks of gestation: retrospective
cohort study. Am J Obstet Gynecol 2016; 215: 98.e1–11.
14. Roman A, Rochelson B, Fox NS, Hoffman M, Berghella V, Patel V, Calluzzo I,
Saccone G, Fleischer A. Efficacy of ultrasound-indicated cerclage in twin pregnancies.
Am J Obstet Gynecol 2015; 212: 788.e1–6.
15. Society for Maternal–Fetal Medicine (SMFM). Electronic address: pubs@smfm.org,
McIntosh J, Feltovich H, Berghella V, Manuck T. The role of routine cervical length
screening in selected high- and low-risk women for preterm birth prevention. Am
J Obstet Gynecol 2016; 215: B2–B7.
16. Gordon MC, McKenna DS, Stewart TL, Howard BC, Foster KF, Higby K, Cypher
RL, Barth WH. Transvaginal cervical length scans to prevent prematurity in twins: a
randomized controlled trial. Am J Obstet Gynecol 2016; 214: 277.e1–7.
17. Smith AH, Bates MN. Confidence limit analyses should replace power calcu-
lation in the interpretation of epidemiologic studies. Epidemiology 1992; 3:
449–452.
18. McNamee R. Regression modelling and other methods to control confounding.
Occup Environ Med 2005; 62: 500–506.
19. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP;
STROBE Initiative. The Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) statement: guidelines for reporting observational studies.
Lancet 2007; 370: 1453–1457.
20. Heyborne KD, Porreco RP, Garite TJ, Phair K, Abril D; Obstetrix/Pediatrix Research
Study Group. Improved perinatal survival of monoamniotic twins with intensive
inpatient monitoring. Am J Obstet Gynecol 2005; 192: 96–101.
21. DeFalco LM, Sciscione AC, Megerian G, Tolosa J, Macones G, O’Shea A, Pollock
MA. Inpatient versus outpatient management of monoamniotic twins and outcomes.
Am J Perinatol 2006; 23: 205–211.
22. Van Mieghem T, De Heus R, Lewi L, Klaritsch P, Kollmann M, Baud D, Vial Y,
Shah PS, Ranzini AC,Mason L, Raio L, Lachat R, Barrett J, Khorsand V,Windrim R,
Ryan G. Prenatal management of monoamniotic twin pregnancies. Obstet Gynecol
2014; 124: 498–506.
23. Murata M, Ishii K, Kamitomo M, Murakoshi T, Takahashi Y, Sekino M, Kiyoshi K,
Sago H, Yamamoto R, Kawaguchi H, Mitsuda N. Perinatal outcome and clinical
features of monochorionic monoamniotic twin gestation. J Obstet Gynaecol Res
2013: 39: 922–925.
24. Quinn KH, Cao CT, Lacoursiere DY, Schrimmer D. Monoamniotic twin pregnancy:
continuous inpatient electronic fetal monitoring – an impossible goal? Am J Obstet
Gynecol 2011; 204: 161.e1–6.
25. Pasquini L, Wimalasudera RC, Fichera A, Barigye O, Chappell L, Fisk NM. High
perinatal survival in monoamniotic twins managed by prohylactic sulindac, intensive
ultrasound surveillance, and Cesarean delivery at 32 weeks’ gestation. Ultrasound
Obstet Gynecol 2006; 28: 681–687.
26. Prefumo F, Fichera A, Pagani G, Marella D, Valcamonico A, Frusca T. The natural
history of monoamniotic twin pregnancies: a case series and systematic review of the
literature. Prenat Diagn 2015; 35: 274–280.
27. Kilby MD, Bricker L on behalf of the Royal College of Obstetricians and
Gynaecologists. Management of monochorionic twin pregnancy. Green Top
Guideline No. 51. BJOG 2016; 124: e1–45.
28. Saccone G, Berghella V. Antenatal corticosteroids for maturity of term or near term
fetuses: systematic review and meta-analysis of randomized controlled trials. BMJ
2016; 355: i5044.
29. Royal College of Obstetricians and Gynaecologists (RCOG). Preterm Labour and
Birth. Royal College of Obstetricians and Gynaecologists: London, UK, 2015.
30. Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating
fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst
Rev 2017; 3: CD004454.
SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article:
Table S1 Details of neonatal deaths according to gestational age at delivery
Table S2 Details of perinatal deaths according to gestational age at delivery
Table S3 Fetal death rates with inpatient and outpatient care, studies published since 2005
Copyright  2018 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2018.
